Skip to main content

Genstruct, Pfizer Expand Research Partnership

NEW YORK, Nov. 8 (GenomeWeb News) - Genstruct said today that it has extended a collaboration with Pfizer on various projects designed to uncover underlying mechanisms of action and toxicities of medicines.

 

The companies began collaborating in January 2003.

 

The new arrangement includes research projects using Genstruct's Molecular Epistemics platform with a number of Pfizer units including Worldwide Safety Sciences, the Proteomics Global Center of Excellence, and Clinical Sciences, said Genstruct.

 

Specific terms of the multi-year deal were not disclosed.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.